Hence, these findings suggested that the abnormal BCAA metabolism in ESCC might be driven in part by the ILF2/ILF3 complex, but the mechanism by whether involvement of the MAPK signaling pathway remains to be explored. The gene discussed is ILF2; the disease is esophageal squamous cell carcinoma.